Prevalence of Alloimmunization against RBC Antigens in Thalassemia Major Patients

Amin  Mirzaeian; Gholamhossein  Tamaddon; Majid  Naderi; Marziyeh  Hosseinpour; Narges  Sargolzaie

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Prevalence of Alloimmunization against RBC Antigens in Thalassemia Major Patients

Author(s):

Amin Mirzaeian¹,

Gholamhossein Tamaddon^2,*,

Majid Naderi³,

Marziyeh Hosseinpour⁴,

Narges Sargolzaie⁵

1Bsc of Laboratory Sciences, Cellular and Molecular Research Center, Shahr-e-Kord University of Medical Sciences, Shahr-e-kord, Iran

2PhD Student of Hematology, Department of laboratory Sciences, Faculty of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, Iran

3Pediatrics Hematologist & Oncologist Ali Ebn-e Abitaleb Hospital Research Center For Children And Adolescents Health [RCCAH], Zahedan University Of Medical Sciences, Zahedan, Iran

4Bsc of Laboratory Sciences, Medical School Zahedan University of Medical Science , Zahedan, Iran

5Assistant Professor of Community Medicine, Community Medicine Department Zahedan University of Medical Science, Zahedan, Iran

Zahedan Journal of Research in Medical Sciences:Vol. 15, issue 7; e92916

Published online:Apr 25, 2013

Article type:Research Article

Received:Nov 06, 2011

Accepted:Feb 20, 2012

How to Cite:Amin MirzaeianGholamhossein TamaddonMajid NaderiMarziyeh HosseinpourNarges SargolzaiePrevalence of Alloimmunization against RBC Antigens in Thalassemia Major Patients.Zahedan J Res Med Sci.15(7):e92916.

Abstract

Background : Regular blood transfusions to treat the patients with thalassemia major generate antibodies acting against red blood cells antigens. This immune response is called alloimmunity. This study was conducted with the purpose of determining the prevalence of alloantibodies and autoantibody, identifying the type of causative antigen, and recognizing the factors affecting alloimmunization among the patients with thalassemia major receiving blood.
Materials and Methods : In this cross-sectional study, 385 patients with thalassemia major participated. After recording their demographic information, serum specimens taken from the patients were screened using pooled cells obtained from Biorad Company. The positive cases were examined to identify antibodies using panel cells obtained from Iranian Blood Transfusion Organization. In this study, SPSS 16 was employed for performing statistical analysis.
Results : Of the 385 patients, 69 subjects (17.9%) comprising 221 men and 164 women had alloantibody. In 57 cases, the antibody type was exactly identified. In 21 patients (5.5%) the existence of autoantibody was determined. The mean ages of the participants were within 14.3±7.5 and 13.3±7.9 years old for male and female groups, respectively. 28 patients had splenectomy and age at the onset of blood transfusion ranged from a month after birth to nine years.
Conclusion : In these patients, the most significant blood group systems acted by alloantibodies were Rh and Kell. Since the results of this study show 17.9% incidence of alloimmunization in these patients, it is recommended to carry out injected blood compatibility test (cross-match) after antibody screening.

Keywords

Thalassemia major

Alloantibody

Cell panel

Fulltext

The full text of this article is available on the PDF file.

References

1.
The References of this article are available on the PDF file.

comments